These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

979 related items for PubMed ID: 11380964

  • 1. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
    Smrcek JM, Baschat AA, Germer U, Gloeckner-Hofmann K, Gembruch U.
    Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
    [Abstract] [Full Text] [Related]

  • 2. Trisomy 21, fetal hydrops, and anemia: prenatal diagnosis of transient myeloproliferative disorder?
    Hendricks SK, Sorensen TK, Baker ER.
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):703-5. PubMed ID: 8378020
    [Abstract] [Full Text] [Related]

  • 3. Prenatal diagnosis of a transient myeloproliferative disorder in trisomy 21.
    Baschat AA, Wagner T, Malisius R, Gembruch U.
    Prenat Diagn; 1998 Jul; 18(7):731-6. PubMed ID: 9706656
    [Abstract] [Full Text] [Related]

  • 4. Fetal hepatosplenomegaly associated with transient myeloproliferative disorder in trisomy 21.
    Macones GA, Johnson A, Tilley D, Wade R, Wapner R.
    Fetal Diagn Ther; 1995 Jul; 10(2):131-3. PubMed ID: 7794514
    [Abstract] [Full Text] [Related]

  • 5. Intrauterine diagnosis and management of transient myeloproliferative disorder.
    Strobelt N, Ghidini A, Locatelli A, Vergani P, Mariani S, Biondi A.
    Am J Perinatol; 1995 Mar; 12(2):132-4. PubMed ID: 7779196
    [Abstract] [Full Text] [Related]

  • 6. The association between congenital heart disease and Down syndrome in prenatal life.
    Paladini D, Tartaglione A, Agangi A, Teodoro A, Forleo F, Borghese A, Martinelli P.
    Ultrasound Obstet Gynecol; 2000 Feb; 15(2):104-8. PubMed ID: 10775990
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reference values of fetal ductus venosus, inferior vena cava and hepatic vein blood flow velocities and waveform indices during the second and third trimester of pregnancy.
    Axt-Fliedner R, Wiegank U, Fetsch C, Friedrich M, Krapp M, Georg T, Diedrich K.
    Arch Gynecol Obstet; 2004 Jul; 270(1):46-55. PubMed ID: 15190437
    [Abstract] [Full Text] [Related]

  • 11. Hypoechoic hepatomegaly associated with transient abnormal myelopoiesis provides clues to trisomy 21 in the third-trimester fetus.
    Hamada H, Yamada N, Watanabe H, Okuno S, Fujiki Y, Kubo T.
    Ultrasound Obstet Gynecol; 2001 May; 17(5):442-4. PubMed ID: 11380972
    [Abstract] [Full Text] [Related]

  • 12. [Ductus venosus agenesis].
    Durakovic N, Azancot A, Eurin D, Menez F, Vuillard E, Garel C, Luton D, Delezoide AL.
    Arch Mal Coeur Vaiss; 2005 May; 98(5):542-8. PubMed ID: 15966606
    [Abstract] [Full Text] [Related]

  • 13. Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops.
    Lambert-Messerlian GM, Saller DN, Tumber MB, French CA, Peterson CJ, Canick JA.
    Prenat Diagn; 1998 Oct; 18(10):1061-7. PubMed ID: 9826898
    [Abstract] [Full Text] [Related]

  • 14. Prenatal diagnosis of congenital leukemia in a fetus at 25 weeks' gestation with Down syndrome: case report and review of the literature.
    Robertson M, De Jong G, Mansvelt E.
    Ultrasound Obstet Gynecol; 2003 May; 21(5):486-9. PubMed ID: 12768562
    [Abstract] [Full Text] [Related]

  • 15. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O.
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cytogenetic evaluation of cystic hygroma associated with hydrops fetalis, oligohydramnios or intrauterine fetal death: the roles of amniocentesis, postmortem chorionic villus sampling and cystic hygroma paracentesis.
    Chen CP, Liu FF, Jan SW, Lee CC, Town DD, Lan CC.
    Acta Obstet Gynecol Scand; 1996 May; 75(5):454-8. PubMed ID: 8677770
    [Abstract] [Full Text] [Related]

  • 18. Management of non-immune hydrops: 8 years' experience.
    Anandakumar C, Biswas A, Wong YC, Chia D, Annapoorna V, Arulkumaran S, Ratnam S.
    Ultrasound Obstet Gynecol; 1996 Sep; 8(3):196-200. PubMed ID: 8915090
    [Abstract] [Full Text] [Related]

  • 19. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.
    Enders M, Weidner A, Zoellner I, Searle K, Enders G.
    Prenat Diagn; 2004 Jul; 24(7):513-8. PubMed ID: 15300741
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.